New & Noteworthy: Upcoming Conference Highlights

At Keystone Symposia, our goal is to illuminate not just cutting edge discoveries, but also entire fields that are emerging at the forefront of science and medicine, such as regenerative cell therapies, AI in biomedical research and many more. These fields have groundbreaking potential by changing our understanding of biology and/or disease processes, making way for innovation in diagnosing, preventing and treating disease. As such, every year we dedicate a handful of conferences specifically to these transformative topics, convening world leaders to chart the path forward for these exciting new research frontiers.  

This year we have a unique line-up of emerging topic conferences that spans basic science to clinical medicine, in fields ranging from developmental biology to drug discovery. Explore new paradigms and expand your horizons with the meetings below, also available via Livestream and/or On Demand!

This conference explores emerging innovations in stem cell models and the design of stem-cell based embryo models (SCBEMs) to study embryogenesis, implantation, organogenesis and other aspects of early development. The program will integrate advances in bioengineering, synthetic biology tools and cell-instructive biomaterials systems that are enabling the engineering of SCBEMs with unprecedented precision.  Exploring research and translational applications, speakers will showcase how these invaluable tools are enhancing the capabilities of disease modeling, drug screening and regenerative and reproductive medicine. The meeting will draw together the community in this emerging and rapidly evolving field to consolidate the ideology and define the next frontier.

February 02–05, 2026

Stromal biology examines how fibroblasts and endothelial cells shape tissue development, function, and pathology through interactions with parenchymal and immune cells. This meeting will focus on stromal regulation of immune-driven outcomes in homeostasis, infection, cancer, autoimmunity, and fibrosis, highlighting new tools to study these processes in vivo. Attendees will gain fresh perspectives on how stromal cells influence immunity and biological function across tissues and diseases, with built-in opportunities for networking and career development. 

The program will also spotlight emerging therapeutic targets and the rapid rise of stromal-directed therapies in the clinic. By uniting researchers across academic, clinical, and industry sectors with diverse expertise, this meeting will break down silos to foster cross-disciplinary collaborations and accelerate translational impacts. 

Jointly held with the Keystone Symposia on Fibrosis: Cross Organ Pathology and Pathways to Clinical Development, this pairing will drive interdisciplinary discovery at the intersection of fibroblast biology, matrix biology, inflammation, and immunity as it relates to disease pathology. Attendees will get full access to both meetings for the price of one! 

Wylie Center and Tupper Manor at Endicott College, Beverly, MA, United States

April 13–16, 2026 

 

Membrane transporters control the movement of nutrients, ions, hormones, neurotransmitters, drugs and toxins across cell membranes, playing vital roles in cellular function. Solute Carrier (SLC) transporters are the largest family of these proteins but remain underutilized as drug targets. To unlock their therapeutic potential, we need deeper insight into their function, mechanisms, regulation, and biological roles, along with better tools, computational modeling, and high-throughput screening technologies. 

This conference brings together experts in SLC transporter pharmacology, physiology, and structure to advance understanding and  build a collaborative research community focused on leveraging SLCs for therapeutic and diagnostic applications. 

---

 

Closing the Data Gap in Global Genomics, Medicine & Population Health 

Herrenhausen Palace, Hannover, Germany

April 27–30, 2026

 

This symposium will explore the global health impact of large-scale, population-based prospective studies. It will highlight scientific discoveries from established longitudinal research and emphasize the importance of strategically located studies for understanding genomic, lifestyle, and environmental drivers of disease around the world. 

In addition to examining genomic variability, the program will showcase advances in using data from wearables, imaging, and blood biomarkers to predict, diagnose, and monitor disease. Discussions will also address the challenges of collecting, curating, accessing and analyzing complex datasets across diverse populations, and how these efforts are being translated into better prevention, diagnosis, and treatment worldwide.  

Return to the September 2025 Keypoint Newsletter